Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients

Fig. 2

Response to induction therapy. The OS was significantly conditioned by the response to therapy, with the median not reached at 12 months by patients in CR compared to only 3 months for those who achieved only a PR or did not respond to treatment (p < 0.001) (a). Also EFS was significantly conditioned, with 43% of patients in CR who were free from events at 12-months versus 18% of those who did not reach a complete response (p < 0.001) (b)

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us